Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Enterprise Value: 2020-2024

Historic Enterprise Value for MDxHealth (MDXH) over the last 5 years, with Dec 2024 value amounting to -$46.8 million.

  • MDxHealth's Enterprise Value rose 35.03% to -$32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.0 million, marking a year-over-year increase of 35.03%. This contributed to the annual value of -$46.8 million for FY2024, which is 379.20% down from last year.
  • According to the latest figures from FY2024, MDxHealth's Enterprise Value is -$46.8 million, which was down 379.20% from $16.8 million recorded in FY2023.
  • MDxHealth's Enterprise Value's 5-year high stood at $22.5 million during FY2022, with a 5-year trough of -$58.5 million in FY2022.
  • In the last 3 years, MDxHealth's Enterprise Value had a median value of -$15.0 million in 2023 and averaged -$16.5 million.
  • As far as peak fluctuations go, MDxHealth's Enterprise Value crashed by 1,218.65% in 2021, and later surged by 146.66% in 2022.
  • Over the past 5 years, MDxHealth's Enterprise Value (MRY) stood at -$3.7 million in 2020, then tumbled by 1,218.65% to -$48.2 million in 2021, then surged by 146.66% to $22.5 million in 2022, then dropped by 25.51% to $16.8 million in 2023, then crashed by 379.20% to -$46.8 million in 2024.
  • Its last three reported values are -$46.8 million in FY2024, $16.8 million for FY2023, and $22.5 million during FY2022.